1Muller M, Kuhn DF, Hinricks B, et al. Is the elimination of osteosarcoma cells with intraoperative "mesh autotransfusion and leukocyte depletion filters possible ? Anesthetist , 1996,45 ( 9 ) ~834-838.
2Edelman MJ, Potter P, Mahaffey KG, et al. The potential for reintroduction of tumor cells during intraoperative blood salvage:reduction of risk with use of the RC-400 Leukocyte depletion filter. Urology, 1996,47(2) : 179-181.
3Hansen E, Knuechel R, Altmeppen J, et al. Blood irradiation for immoperative autotransfusion in cancer surgery :demonstration of efficient elimination of contaminating tumor cells. Transfusion,1999,39(6) :608-615.
4Vogt M, Bothner U,Brinkmann A, et al. Peri-operative tolerance to large-dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin. Anaesthesia, 1999,54(2):121-124.
5Lin JS, Tzeng CH,Hao TC, et al. Cytokine release in febrile nonhaemolytic red cell transfusion reactions. Vox Sang, 2002,82 (3) :156-160.
6Heddle NM, Klama L, Meyer R, et al. Randomized controlled trail comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion, 1999,39 (6) : 231-238.
7McCullough J.National blood programs in developed countries.Advisory Committee on Blood Safety and Availability,22nd Meeting,January 2004.Available at http://www.hhs.gov/bloodsafety
8Strategies For Increasing The U.S.Blood Supply.Interagency Working Group on Blood Safety and Availability,August 1999.Available at http://www.hhs.gov/bloodsafety/increaseblood.html
9Dodd RY,Orton SL,Notari IV EP et al,Viral marker rates among blood donors before and after the terrorist attacks on the US on September 11,2001[J].Transfusion,2002,42:1240
10Doddridge D.National Blood Reserve.Advisory Committee on Blood Safety and Availability,22nd Meeting,January 2004.Available at http://www.hhs.gov/bloodsafety
